Research Article
Impact of Diabetes and Hyperglycemia on Survival in Advanced Breast Cancer Patients
Table 1
Clinical and pathological characteristics in nondiabetic and diabetic patients.
| | | Nondiabetics | Diabetics | Univariate (P) |
| | Median age (Years) | 48.0 | 52.5 | 0.207 | | T | | | | | 1 | 27 (12%) | 4 (9%) | 0.684 | | 2 | 77 (34%) | 12 (29%) | | 3 | 54 (24%) | 14 (35%) | | 4 | 67 (30%) | 10 (27%) |
| | N | | | | | 0 | 41 (18%) | 9 (23%) | 0.695 | | 1 | 95 (42%) | 14 (34%) | | 2 | 56 (25%) | 8 (20%) | | 3 | 33 (15%) | 9 (23%) |
| | Grade | | | | | 1 | 29 (13%) | 7 (18%) | 0.087 | | 2 | 81 (36%) | 20 (49%) | | 3 | 115 (51%) | 13 (33%) |
| | Hormone receptor | | | | | Positive | 112 (49%) | 28 (70%) | 0.018 | | Negative | 113 (51%) | 12 (30%) |
| | HER2 | | | | | Positive | 60 (27%) | 5 (13%) | 0.079 | | Negative | 165 (73%) | 35 (87%) |
| | Triple-negative | | | | | Positive | 59 (26%) | 7 (18%) | 0.262 | | Negative | 166 (74%) | 33 (82%) |
| | Metastatic site | | | | | Single | 122 (54%) | 18 (45%) | 0.306 | | Multiple | 103 (46%) | 22 (55%) |
| | Type of metastases | | | | | Nonvisceral | 86 (38%) | 16 (40%) | 0.790 | | Visceral | 139 (62%) | 24 (60%) |
| | Median BMI at recurrence | 26.8 | 27.5 | 0.359 |
|
|
T: tumor stage according to TNM; N: nodal stage according to TNM; BMI: body mass index.
|
